Please ensure Javascript is enabled for purposes of website accessibility

Better Cannabis Stock: Aphria vs. Sundial Growers

By Keith Speights - Mar 4, 2021 at 5:08AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of these stocks stands out as the clear winner.

Aphria (APHA) and Sundial Growers (SNDL 2.02%) rank as two of the most talked-about cannabis stocks around right now. They're also two of the hottest cannabis stocks. Aphria's shares have jumped more than 160% year to date while Sundial stock has soared more than 170%. 

But generating a lot of buzz and past gains don't necessarily mean that a stock will be successful going forward. Which of these two cannabis stocks is the better pick now? Here's how Aphria and Sundial stack up against each other.

Cannabis leaf on top of a $100 bill partially covering Ben Franklin's face

Image source: Getty Images.

The case for Aphria

If you prefer to go big or go home, Aphria could be just the stock you're looking for. It's set to become the biggest cannabis producer in the world soon with a merger with Tilray (TLRY).

The combination of Aphria and Tilray should give the resulting entity a No. 1 market share in the Canadian retail cannabis market. The addition of Tilray's Portugal operations with Aphria's CC Pharma distribution business will also boost the company's position in the expanding European medical cannabis market.

Of course, the biggest prize of all is the U.S. market. Aphria now has its foot in the door in that market thanks to its acquisition in November of SweetWater Brewing. The Atlanta-based craft brewer has built a lineup of brands closely aligned with the cannabis lifestyle, including its flagship 420 Extra Pale Ale brand. The merger with Tilray will bring leading hemp foods maker Manitoba Harvest into the fold.

The combined company will assume the Tilray name once the transaction closes, which is expected to happen in the second quarter. However, Aphria is definitely the controlling player in the deal. Current Aphria chairman and CEO Irwin Simon will retain those roles in the new company. Aphria will also hold seven of the nine seats on the board of directors.

In the meantime, Aphria's financial position looks better than most other Canadian cannabis companies. Aphria reported year-over-year revenue growth of 33% in its latest quarter. It also generated higher positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for the seventh consecutive quarter.

The case for Sundial Growers

It might seem like nearly everyone is talking about Sundial Growers these days. Reddit and Robinhood users have helped drive impressive gains for the small Canadian marijuana stock over the last couple of months. 

Sundial operates a 470,000-square-foot cannabis facility in Alberta. It markets four adult-use cannabis brands that target all price-points from value to premium. The company claims a nationwide market share of around 3.3%. Sundial is strongest in the province of Quebec, where its market share tops 4%. 

The company struggled somewhat in 2020. Sundial's net cannabis revenue fell 36% in the third quarter from the previous quarter. It also posted a hefty net loss and worsening negative adjusted EBITDA.

However, there is some good news on the financial front for Sundial. In December, the company completed a restructuring that completely wiped out its debt. And unlike some Reddit-fueled high-flyers, Sundial took advantage of its tremendous gains by issuing new shares to raise additional cash. 

Sundial appears to have resolved some issues with its cultivation processes that weighed on its Q3 performance. It's also transitioning more to branded products from selling wholesale. As the Canadian cannabis market grows, Sundial could see its financial position improve significantly.

Better cannabis stock?

I think the choice between these two cannabis stocks is an easy one. Aphria is the clear winner. Its financial position is stronger. It's growing faster. And it will soon become the top cannabis company in the world. 

However, I'm not really a fan of either of these stocks right now. Why? There are several other cannabis stocks that have even better growth prospects.

In particular, I like some U.S.-based cannabis companies. The stocks are generally more attractively valued than their Canadian peers. And with more states legalizing marijuana, their opportunities are expanding. Aphria beats Sundial, in my view, but there are a handful of U.S. pot stocks that beat Aphria.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote
Aphria
APHA
Tilray Stock Quote
Tilray
TLRY
Sundial Growers Inc. Stock Quote
Sundial Growers Inc.
SNDL
$0.33 (2.02%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.